However, the percentage of Foxp3+ cells in CD4+ T cells was increased in the spleen, blood, and tumor tissue by 15%–50% in mice treated with BLM (Figure 1C, E–F, P < 0.05). The gene discussed is CD4; the disease is neoplasm.